XML 47 R36.htm IDEA: XBRL DOCUMENT v3.25.2
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Product Information [Line Items]      
Cumulative net losses $ 571,374,000   $ 561,725,000
Restricted cash     200,000
Short-term investments  
Expected credit loss on investments or accrued interest, description The Company did not have any material expected credit losses on investments or material expected credit losses on accrued interest related to investments during the six months ended June 30, 2025, or year ended December 31, 2024    
Revenue, Remaining Performance Obligation, Amount $ 12,200,000    
Contract with customer liability revenue recognized 4,900,000 $ 4,300,000  
Capitalized contract cost $ 100,000   100,000
Expected dividend rate 0.00%    
Expected volatility 75.00%    
Expected term 6 years 3 months    
Series A Convertible Preferred Stock [Member]      
Product Information [Line Items]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 49,825,183    
Stock Options and Stock Appreciation Rights [Member]      
Product Information [Line Items]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 4,371,340    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 3.49    
Restricted Stock [Member]      
Product Information [Line Items]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 2,380,625    
2021 CEO Performance Award Unit Grant [Member]      
Product Information [Line Items]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 13,000,000    
Unearned Restricted Shares [Member]      
Product Information [Line Items]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 0    
Revenue From System Delivery and Installation [Member] | Product Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk percentage 31.00% 25.00%  
Disposable Revenue [Member] | Product Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk percentage 34.00% 28.00%  
Other Recurring Revenue [Member] | Product Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk percentage 35.00% 47.00%  
Systems [Member]      
Product Information [Line Items]      
Warranty costs $ 100,000 $ 100,000  
Royalty [Member]      
Product Information [Line Items]      
Royalty revenue 0 $ 100,000  
Other Current Assets [Member] | Maximum [Member]      
Product Information [Line Items]      
Accrued interest receivable $ 100,000   $ 100,000